Remove Cancer Remove Cholesterol Remove Lipid disorders
article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. Wegovy may cause serious side effects, including: Possible thyroid tumors, including cancer. These may be symptoms of thyroid cancer. 10,11 In the U.S.,

Obesity 111